KARLA HOPKINS: Open Payments
NPI 1699447730 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 15 payments from 10 companies in 2025. Trend: 2023 $412 · 2024 $495 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $100 |
| Corium, LLC | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Lundbeck LLC | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Noven Therapeutics, LLC | 1 | $21 |
| Neos Therapeutics, LP | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: VRAYLAR, REXULTI, Azstarys, CAPLYTA, AUSTEDO XR, HETLIOZ, Xelstrym, Adzenys XR-ODT.
Industry payments across KY — which companies pay providers there.
